SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR),

  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young
  Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc.
                  (CBOU) and Somaxon Pharmaceuticals (SOMX)

PR Newswire

NEW YORK, Dec. 18, 2012

NEW YORK, Dec. 18, 2012 /PRNewswire/ --

Young Innovations, Inc.

Levi & Korsinsky is investigating the Board of Directors of Young Innovations,
Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company to an
affiliate of Linden Capital Partners for $39.50 per share. Young Innovations
stock traded above the offer price as recently as September 27, 2012.

Click here to learn more about the investigation:
http://zlk.9nl.com/young-innovations-ydnt/, or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Compuware Corp.

Levi & Korsinsky is investigating the Board of Directors of Compuware Corp.
(NasdaqGS: CPWR) for possible breaches of fiduciary duty and other violations
of state law in connection with a going private proposal from Elliott
Management Corp. ("Elliott") under which Elliott would acquire the outstanding
shares of Compuware it does not currently own for a value of $11 per share.
At least one analyst set a price target for Compuware stock at $12.00 per
share.

Click here to learn how to join the action:
http://zlk.9nl.com/compuware-cpwr/, or call: 877-363-5972.

Caribou Coffee Co. Inc.

Levi & Korsinsky is investigating the Board of Directors of Caribou Coffee Co.
Inc. (Nasdaq: CBOU) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company to Joh. A.
Benckiser Group for $16 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/caribou-coffee-cbou/, or call: 877-363-5972.

Somaxon Pharmaceuticals

Levi & Korsinsky is investigating the Board of Directors of Somaxon
Pharmaceuticals, Inc. (NasdaqCM: SOMX) for possible breaches of fiduciary duty
and other violations of state law in connection with the sale of the Company
to Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX).

Click here to learn more about the investigation:
http://zlk.9nl.com/somaxon-pharmaceuticals-somx/, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com